News

EXCLUSIVE: Two brothers were shocked when diagnosed with prostate cancer within a month of each other. But luckily that ...
An experimental treatment called VERVE-102 lowers the amount of "bad" cholesterol in the blood of people with specific ...
During a live event, Jahan Aghalar, MD, discussed key NCCN-recommended oral therapies and landmark trials for metastatic ...
Data from clinical trials have indicated that PSA is prognostic for outcomes, but little is known about real-world trends.
Dear W.D.W.: It is completely understandable to be concerned about a PSA level of 18 ng/mL, but you and your urologist have, ...
Prostate cancer is a stealthy disease with no attention-grabbing symptoms at first. It’s also a private and sensitive topic that men don’t want to discuss. But for men age 40 and older, it’s a good ...
I am a healthy 89-year-old United States Army veteran. In August 2017, I was diagnosed with advanced prostate cancer and was ...
At this time, I suspect your doctor will order some radiology tests, possibly a bone scan to look for the distant spread of ...
I am a healthy 89-year-old United States Army veteran. In August 2017, I was diagnosed with advanced prostate cancer and was ...
To close out Men’s Health Month, the Cancer Connections team sat down with Dr. William Dahut, the American Cancer Society’s ...
The global Psoriatic Arthritis (PsA) Treatment Market is set to acquire a value of USD 11,973.7 million in 2024. By 2034, the value of the psoriatic arthritis (PsA) treatment market is slated to shoot ...
In real-world patients with mHSPC, a PSA cutoff of 0.2 ng/mL after 6 to 12 months of intensified hormone therapy predicts survival outcomes.